查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908231

基因組編輯市場規模、佔有率和趨勢分析報告：按技術、交付方式、應用、模式、最終用途、地區和細分市場預測（2026-2033 年）

Genome Editing Market Size, Share & Trends Analysis Report By Technology, By Delivery Method, By Application, By Mode, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基因組編輯市場概覽

全球基因組編輯市場預計到 2025 年將價值 113.7 億美元，預計到 2033 年將達到 398.1 億美元。

預計從 2026 年到 2033 年，該產業將以 17.03% 的複合年成長率成長。這一成長可歸因於臨床前模型的成功推動了對基因組編輯療法的需求，市場參與企業之間為業務發展而日益激烈的競爭，基因編輯技術的進步，以及農業生物技術領域的日益普及。

新冠感染疾病對市場造成了重大衝擊，擾亂了包括臨床試驗中斷、供應鏈挑戰和嚴格監管在內的許多方面。封鎖措施、旅行限制和勞動力減少也對生產和供應鏈造成了影響，導致基因治療產品的生產和分銷延誤。儘管面臨這些挑戰，基因組編輯行業的公司已透過實施適應性策略來適應新常態，並有望從新冠疫情的影響中恢復過來。疫情加速了基因修飾技術的研究和開發活動，尤其是在迫切需要有效的新冠病毒治療方法和疫苗的情況下。例如，南洋理工大學的研究人員於2021年3月開發了VaNGuard（變異核苷酸衛士）診斷測試，該測試能夠檢測出帶有突變的SARS-CoV-2株。這項進展可望加速CRISPR基因組編輯技術的應用。

基於CRISPR技術的工具的快速發展顯著推動了基因組編輯產業的擴張。創新基因組編輯工具的出現，使得基因組DNA的操作更加便捷，為治療方法研發和疾病檢測開闢了新的途徑，進而推動了罕見疾病基因組編輯產業的成長。因此，服務供應商擁有進入這一先前尚未開發的領域的盈利機會。此外，政府投入的增加、基因改造作物產量的擴大以及基因組計劃的增多，預計也將進一步促進市場成長。

許多公司已與技術開發商簽訂授權協議以增強其市場地位，而主要企業則透過收購和合作等策略舉措擴大其全球企業發展。例如，2024年2月，Precision BioSciences授予Caribou Biosciences一項非獨家全球許可，允許其使用Precision BioSciences的專利技術，該技術可將外源抗原結合受體靶向插入人類T細胞的TRAC基因座。該協議包括預付款、產品銷售分成以及潛在的里程碑付款。

基因編輯技術CRISPR是生物技術領域一項快速發展的技術。 CRISPR利用細菌的免疫系統來敲除基因或插入新的基因。傳統的基因組編輯方法速度慢、效率低、勞力密集，無法適應基因組改造的快速發展時代。此外，這項技術正在各個領域帶來變革性成果，包括植物、動物和細胞株的基因工程，以及藥物研發和監測，從而推動市場成長。此技術具有探索不同基因組合、調控基因表現以及闡明單一DNA鹼基作用的潛力。

基因組學及相關技術的進步對作物遺傳學產生了重大影響。如今，對許多作物物種的基因組和轉錄組進行定序已成為可能。基因工程工具在農業領域的主要優勢包括開發具有各種先進性狀（例如提高產量）的基因改造植物和作物。它們還有助於保護生物多樣性、減少農業對環境的影響、緩解氣候變遷以及減輕貧困和飢餓。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 基因組編輯市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 基因組編輯市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析
    • 新冠疫情影響分析

第4章 基因組編輯市場：依技術、估算與趨勢分析

  • 依技術分析全球基因組編輯市場波動狀況
  • 全球基因組編輯市場規模及趨勢分析（依技術分類，2021-2033 年）
  • （CRISPR）/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganucleases
  • 其他

第5章 基因組編輯市場：以交付方式分類的估算與趨勢分析

  • 以交付方式分析全球基因組編輯市場的變化
  • 全球基因組編輯市場規模及趨勢分析（依交付方式分類，2021-2033 年）
  • 體外
  • 體內

第6章 基因組編輯市場：按應用分類的估算與趨勢分析

  • 全球基因組編輯市場按應用領域分類的波動分析
  • 全球基因組編輯市場規模及趨勢分析（按應用領域分類，2021-2033 年）
  • 基因工程
    • 細胞株工程
    • 動物基因工程
    • 植物性因工程
    • 其他
  • 臨床應用
    • 診斷藥物研發
    • 治療方法研發

第7章 基因組編輯市場：依模式分類的估算與趨勢分析

  • 全球基因組編輯市場模式差異分析
  • 全球基因組編輯市場規模及趨勢分析（依模式分類，2021-2033 年）
  • 合約
  • 內部

第8章：基因組編輯市場：依最終用途分類的估算與趨勢分析

  • 全球基因組編輯市場最終用途差異分析
  • 全球基因組編輯市場規模及趨勢分析（依最終用途分類，2021-2033 年）
  • 生物技術和製藥公司
  • 學術和政府研究機構
  • 受託研究機構

第9章 基因組編輯市場：區域、預測與趨勢分析

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2025年商業市場分析
  • 公司簡介/列表
    • Merck KGaA
    • Takara Bio Inc.
    • Revvity, Inc.
    • Danaher Corporation
    • GenScript
    • New England Biolabs
    • Charles River Laboratories
    • Eurofins Scientific
    • Lonza
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-1-68038-399-7

Genome Editing Market Summary

The global genome editing market size was estimated at USD 11.37 billion in 2025 and is projected to reach USD 39.81 billion by 2033, growing at a CAGR of 17.03% from 2026 to 2033. This growth can be attributed to the success in preclinical models driving the demand for genome editing therapeutics, rising competition among market participants for business development, technological advancements in gene editing technologies, and increasing adoption in agricultural biotechnology.

The COVID-19 pandemic had a significant impact on the market, causing disruptions in several aspects of the market including clinical trial disruptions, supply chain challenges, and stringent regulations. Manufacturing & supply chains were also affected by lockdown measures, travel restrictions, and reduced workforce, leading to delays in the production & distribution of gene therapy products. Despite these challenges, companies in the genome editing industry have adjusted to the new normal by implementing adaptive measures and are expected to recover from the impact of COVID-19. The pandemic accelerated R&D activities in gene alteration technologies, specifically in response to the urgent need for effective treatments and vaccines for COVID-19. For example, researchers at Nanyang Technological University developed the VaNGuard (Variant Nucleotide Guard) diagnostic test in March 2021, which has the capability to detect SARS-CoV-2 strains with mutations. This advancement is anticipated to leverage the utilization of CRISPR genome editing technology.

The rapid evolution of CRISPR-based tools has significantly led to the expansion of the genome editing industry. The emergence of innovative genome editing tools, which allow easier manipulation of genomic DNA, has brought in a new phase in therapeutic development and disease detection, which derives the growth in rare disease genome editing industry. Consequently, service providers now have a profitable opportunity to tap previously unexplored areas in this field. Moreover, increasing government funding, growing production of genetically modified crops, and a rising number of genomics projects are expected to drive market growth.

Many companies are entering into licensing agreements with technology developers to strengthen their market presence, while key players are engaged in strategic initiatives like acquisitions and partnerships to expand their global presence. For instance, in February 2024, Precision BioSciences granted Caribou Biosciences a non-exclusive, global license to use its patented technology for targeted insertion of exogenous antigen binding receptors into the TRAC gene locus of human T cells. This agreement includes upfront payment, royalties on product sales, and potential milestone payments.

Gene editing technology CRISPR is projected to be the burgeoning technology in biotechnology. CRISPR harnesses the bacterial immune system to either knock genes out or insert new genes. Due to their time-consuming, ineffective, and labor-intensive nature, traditional genome editing methods are only partially capable of keeping pace with the rapidly evolving genome modification era. In addition, technology also provides transformative results in various fields, such as plant, animal, & cell line genetic engineering and drug development & monitoring, which results in growth of the market. Technology has the potential to investigate different gene combinations, control gene expression, and find the role of individual DNA bases.

Advancements in genomics and related technologies have significantly impacted crop genetics. Genomes and transcriptomes can now be sequenced for many crops. Major benefits of gene manipulation tools in agricultural sectors include the development of Genetically Modified (GM) plants/crops with various advanced features, such as increased crop productivity. They also help conserve biodiversity, reduce agricultural eco-footprint, mitigate climate change, and aid in alleviating poverty and hunger.

Global Genome Editing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global genome editing market report based on technology, delivery method, application, mode, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • (CRISPR)/Cas9
  • TALENs/MegaTALs
  • ZFN
  • Meganucleases
  • Others
  • Delivery Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Ex-vivo
  • In-vivo
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Genetic Engineering
    • Cell line engineering
    • Animal genetic engineering
    • Plant genetic engineering
    • Others
  • Clinical Applications
    • Diagnostics Development
    • Therapy Development
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Contract
  • In-house
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biotechnology and pharmaceutical companies
  • Academic and government research institutes
  • Contract research organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Delivery Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. Mode Segment
    • 1.2.5. End Use Segment
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Genome Editing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Success in pre-clinical models drives demand for genome editing therapeutics
      • 3.2.1.2. Rising competition amongst market participants for business development
      • 3.2.1.3. Easy editing solutions for the development of therapeutics for a broad range of diseases
      • 3.2.1.4. Increasing demand for synthetic genes and genetically modified organisms
      • 3.2.1.5. Technological advancements in gene editing technologies
      • 3.2.1.6. Rising adoption in agricultural biotechnology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges concerning clinical translation
      • 3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
      • 3.2.2.3. Off-target effects of CRISPR technology
  • 3.3. Genome Editing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Genome Editing Market Technology Movement Analysis
  • 4.3. Global Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. (CRISPR)/Cas9
    • 4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. TALENs/MegaTALs
    • 4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. ZFN
    • 4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Meganuclease
    • 4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Genome Editing Market Delivery Method Movement Analysis
  • 5.3. Global Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
  • 5.4. Ex Vivo
    • 5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. In-Vivo
    • 5.5.1. In-vivo market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Genome Editing Market Application Movement Analysis
  • 6.3. Global Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Genetic Engineering
    • 6.4.1. Genetic Engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Cell Line Engineering
      • 6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Animal Genetic Engineering
      • 6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.4. Plant Genetic Engineering
      • 6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Clinical Applications
    • 6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Diagnostics Development
      • 6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Therapy Development
      • 6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Genome Editing Market Mode Movement Analysis
  • 7.3. Global Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 7.4. Contract
    • 7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. In-house
    • 7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Genome Editing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Genome Editing Market End-Use Movement Analysis
  • 8.3. Global Genome Editing Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Biotechnology and pharmaceutical companies
    • 8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Academic and government research institutes
    • 8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Contract research organizations
    • 8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2025 & 2033
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.4. North America
    • 9.4.1. U.S.
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Target disease prevalence
      • 9.4.1.4. Competitive scenario
      • 9.4.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.2. Canada
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.3. Mexico
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Europe
    • 9.5.1. UK
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Target disease prevalence
      • 9.5.1.4. Competitive scenario
      • 9.5.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.2. Germany
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.3. France
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.4. Italy
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Target disease prevalence
      • 9.5.4.4. Competitive scenario
      • 9.5.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.5. Spain
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Target disease prevalence
      • 9.5.5.4. Competitive scenario
      • 9.5.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.6. Norway
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Target disease prevalence
      • 9.5.6.4. Competitive scenario
      • 9.5.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.7. Sweden
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Target disease prevalence
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Competitive scenario
      • 9.5.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Target disease prevalence
      • 9.5.8.4. Competitive scenario
      • 9.5.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Japan
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Target disease prevalence
      • 9.6.1.4. Competitive scenario
      • 9.6.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Target disease prevalence
      • 9.6.2.4. Competitive scenario
      • 9.6.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.3. India
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Target disease prevalence
      • 9.6.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.4. Australia
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Target disease prevalence
      • 9.6.5.4. Competitive scenario
      • 9.6.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.6. Thailand
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Target disease prevalence
      • 9.6.6.3. Regulatory framework
      • 9.6.6.4. Competitive scenario
      • 9.6.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Brazil
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Target disease prevalence
      • 9.7.1.4. Competitive scenario
      • 9.7.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.2. Argentina
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Target disease prevalence
      • 9.7.2.4. Competitive scenario
      • 9.7.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8. MEA
    • 9.8.1. South Africa
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Target disease prevalence
      • 9.8.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.2. Saudi Arabia
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Target disease prevalence
      • 9.8.2.4. Competitive scenario
      • 9.8.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.3. UAE
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Target disease prevalence
      • 9.8.3.4. Competitive scenario
      • 9.8.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.8.4. Kuwait
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Target disease prevalence
      • 9.8.4.4. Competitive scenario
      • 9.8.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2025
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Takara Bio Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Revvity, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher Corporation
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. GenScript
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. New England Biolabs
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Charles River Laboratories
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Eurofins Scientific
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Lonza
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Thermo Fisher Scientific, Inc.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global genome editing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 4 Global genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 5 Global genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 7 Global genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 8 Global genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 9 Global genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 10 North America genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 11 North America genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 12 North America genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 13 North America genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 14 North America genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 15 North America genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 16 North America genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 17 North America genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 18 U.S. genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 19 U.S. genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 20 U.S. genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 21 U.S. genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 22 U.S. genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 23 U.S. genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 24 U.S. genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Canada genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Canada genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 27 Canada genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Canada genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 29 Canada genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 30 Canada genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 31 Canada genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Mexico genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Mexico genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 34 Mexico genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 35 Mexico genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 36 Mexico genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 37 Mexico genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 38 Mexico genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Europe genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 40 Europe genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 41 Europe genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 42 Europe genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 43 Europe genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 44 Europe genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 45 Europe genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 46 Europe genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Germany genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Germany genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 49 Germany genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 50 Germany genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 51 Germany genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 52 Germany genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 53 Germany genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 54 UK genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 55 UK genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 56 UK genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 57 UK genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 58 UK genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 59 UK genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 60 UK genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 61 France genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 62 France genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 63 France genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 64 France genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 65 France genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 66 France genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 67 France genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 68 Italy genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 69 Italy genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 70 Italy genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 71 Italy genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 72 Italy genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 73 Italy genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 74 Italy genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Spain genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 76 Spain genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 77 Spain genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 78 Spain genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 79 Spain genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 80 Spain genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 81 Spain genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Denmark genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 83 Denmark genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 84 Denmark genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 85 Denmark genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 86 Denmark genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 87 Denmark genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 88 Denmark genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Sweden genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 90 Sweden genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 91 Sweden genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 92 Sweden genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 93 Sweden genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 94 Sweden genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 95 Sweden genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Norway genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 97 Norway genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 98 Norway genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 99 Norway genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 100 Norway genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 101 Norway genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 102 Norway genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 103 Asia Pacific genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 104 Asia Pacific genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 105 Asia Pacific genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 106 Asia Pacific genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 107 Asia Pacific genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 108 Asia Pacific genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 109 Asia Pacific genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 110 Asia Pacific genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 111 China genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 112 China genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 113 China genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 114 China genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 115 China genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 116 China genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 117 China genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 118 Japan genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 119 Japan genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 120 Japan genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 121 Japan genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 122 Japan genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 123 Japan genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 124 Japan genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 125 India genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 126 India genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 127 India genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 128 India genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 129 India genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 130 India genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 131 India genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 132 South Korea genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 133 South Korea genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 134 South Korea genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 135 South Korea genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 136 South Korea genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 137 South Korea genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 138 South Korea genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 139 Australia genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 140 Australia genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 141 Australia genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 142 Australia genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 143 Australia genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 144 Australia genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 145 Australia genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 146 Thailand genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 147 Thailand genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 148 Thailand genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 149 Thailand genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 150 Thailand genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 151 Thailand genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 152 Thailand genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 153 Latin America genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 154 Latin America genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 155 Latin America genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 156 Latin America genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 157 Latin America genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 158 Latin America genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 159 Latin America genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 160 Latin America genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 161 Brazil genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 162 Brazil genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 163 Brazil genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 164 Brazil genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 165 Brazil genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 166 Brazil genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 167 Brazil genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 168 Argentina genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 169 Argentina genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 170 Argentina genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 171 Argentina genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 172 Argentina genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 173 Argentina genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 174 Argentina genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 175 MEA genome editing market, by country, 2021 - 2033 (USD Million)
  • Table 176 MEA genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 177 MEA genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 178 MEA genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 179 MEA genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 180 MEA genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 181 MEA genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 182 MEA genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 183 South Africa genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 184 South Africa genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 185 South Africa genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 186 South Africa genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 187 South Africa genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 188 South Africa genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 189 South Africa genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 190 Saudi Arabia genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 191 Saudi Arabia genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 192 Saudi Arabia genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 193 Saudi Arabia genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 194 Saudi Arabia genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 195 Saudi Arabia genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 196 Saudi Arabia genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 197 UAE genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 198 UAE genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 199 UAE genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 200 UAE genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 201 UAE genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 202 UAE genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 203 UAE genome editing market, by end use, 2021 - 2033 (USD Million)
  • Table 204 Kuwait genome editing market, by technology, 2021 - 2033 (USD Million)
  • Table 205 Kuwait genome editing market, by delivery method, 2021 - 2033 (USD Million)
  • Table 206 Kuwait genome editing market, by application, 2021 - 2033 (USD Million)
  • Table 207 Kuwait genome editing market, for genetic engineering, by application, 2021 - 2033 (USD Million)
  • Table 208 Kuwait genome editing market, for clinical applications, by application, 2021 - 2033 (USD Million)
  • Table 209 Kuwait genome editing market, by mode, 2021 - 2033 (USD Million)
  • Table 210 Kuwait genome editing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Genome editing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Segment snapshot - 3
  • Fig. 16 Competitive landscape snapshot
  • Fig. 17 Life science tools market value, 2025 (USD billion)
  • Fig. 18 Market trends & outlook
  • Fig. 19 PESTEL analysis
  • Fig. 20 Porter's five forces analysis
  • Fig. 21 Genome editing market: Technology outlook key takeaways
  • Fig. 22 Genome editing market: Technology movement analysis
  • Fig. 23 CRISPR/Cas9 market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 TALENs/MegaTALs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 ZFN market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Meganucleases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Genome editing market: Delivery method outlook key takeaways
  • Fig. 29 Genome editing market: Delivery method movement analysis
  • Fig. 30 Ex vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 In vivo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Genome editing market: Application outlook key takeaways
  • Fig. 33 Genome editing market: Application movement analysis
  • Fig. 34 Genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Cell line engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Animal genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Plant genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Clinical applications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Diagnostics development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Therapy development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Genome editing market: Mode outlook key takeaways
  • Fig. 43 Genome editing market: Mode movement analysis
  • Fig. 44 Contract market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 In-house market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Genome editing market: End Use outlook key takeaways
  • Fig. 47 Genome editing market: End Use movement analysis
  • Fig. 48 Biotechnology and pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Academic and government research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)